UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809

Annals of oncology, 2011-06, Vol.22 (6), p.1382-1391

2011

Volltextzugriff (PDF)

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

British journal of haematology, 2003-05, Vol.121 (3), p.439-447

2003

Volltextzugriff (PDF)

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

British journal of haematology, 2008-11, Vol.143 (3), p.395-403

2008

Volltextzugriff (PDF)

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non‐hodgkin lymphoma

Cancer, 2002-08, Vol.95 (3), p.576-580

2002

Volltextzugriff (PDF)

Outpatient reinduction therapy with gemcitabine, dexamethasone, Cisplatin (GDP) for patients with relapsed and refractory lymphoma

Gan to kagaku ryoho, 2015-01, Vol.42 (1), p.51

2015

Volltextzugriff (PDF)

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis

European journal of nuclear medicine and molecular imaging, 2019-01, Vol.46 (1), p.65-79

2019

Volltextzugriff (PDF)

Midtreatment 18F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma

Cancer, 2011-03, Vol.117 (5), p.1010-1018

2011

Volltextzugriff (PDF)

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

Annals of oncology, 2004-03, Vol.15 (3), p.511-516

2004

Volltextzugriff (PDF)

A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype

PloS one, 2013-10, Vol.8 (10), p.e76999-e76999

2013

Volltextzugriff (PDF)

Transformation of Marginal Zone Lymphoma (and association with other lymphomas)

Best practice & research. Clinical haematology, 2017-03, Vol.30 (1-2), p.131-138

2017

Volltextzugriff (PDF)

Adrenal insufficiency caused by primary aggressive non-Hodgkin's lymphoma of bilateral adrenal glands : report of a case and literature review

Annals of hematology, 1999-03, Vol.78 (3), p.151-154

1999

Volltextzugriff (PDF)

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

Annals of oncology, 2007-01, Vol.18 (1), p.149-157

2007

Volltextzugriff (PDF)

Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma

Medical oncology (Northwood, London, England), 2014-05, Vol.31 (5), p.944, Article 944

2014

Volltextzugriff (PDF)

Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin’s lymphoma

Annals of oncology, 2008-04, Vol.19 (4), p.752-762

2008

Volltextzugriff (PDF)

A long-term follow-up study of prospective 80%-dose CHOP followed by involved-field radiotherapy in elderly lymphoma patients

Japanese journal of clinical oncology, 2011-06, Vol.41 (6), p.764-769

2011

Volltextzugriff (PDF)

The role of positron emission tomography (PET) in the management of lymphoma patients

Annals of oncology, 1999-10, Vol.10 (10), p.1181-1184

1999

Volltextzugriff (PDF)

Chemotherapy for malignant lymphoma in Western countries and Japan

Gan to kagaku ryoho, 1993-12, Vol.20 (16), p.2472

Tobinai, K

1993

Volltextzugriff (PDF)

Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Leukemia & lymphoma, 2009-01, Vol.50 (3), p.380-386

2009

Volltextzugriff (PDF)

Recent progress in the treatment of malignant lymphoma

Gan to kagaku ryoho, 1994-07, Vol.21 (8), p.1151

1994

Volltextzugriff (PDF)

Aggressive primary hepatic lymphoma in chinese patients. Presentation, pathologic features, and outcome

Cancer, 1995-10, Vol.76 (8), p.1336-1343

1995

Volltextzugriff (PDF)

Sternal resection for primary or secondary tumors

The Journal of thoracic and cardiovascular surgery, 1997-07, Vol.114 (1), p.93-99

1997

Volltextzugriff (PDF)

A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: Long-term results

Annals of oncology, 1999-12, Vol.10 (12), p.1489-1492

1999

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(19)

Publikationsform

Artikel
(22)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Phase III trial of CHOP-21 versus CHOP-14 for aggressive non-Hodgkin’s lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG 9809

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

Prophylactic intrathecal methotrexate and hydrocortisone reduces central nervous system recurrence and improves survival in aggressive non‐hodgkin lymphoma

Outpatient reinduction therapy with gemcitabine, dexamethasone, Cisplatin (GDP) for patients with relapsed and refractory lymphoma

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis

Midtreatment 18F‐fluorodeoxyglucose positron‐emission tomography in aggressive non‐Hodgkin lymphoma

Rituximab–EPOCH, an effective salvage therapy for relapsed, refractory or transformed B-cell lymphomas: results of a phase II study

A comprehensive comparative analysis of the histomorphological features of ALK-rearranged lung adenocarcinoma based on driver oncogene mutations: frequent expression of epithelial-mesenchymal transition markers than other genotype

Transformation of Marginal Zone Lymphoma (and association with other lymphomas)

Adrenal insufficiency caused by primary aggressive non-Hodgkin's lymphoma of bilateral adrenal glands : report of a case and literature review

Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)

Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma

Prognostic factors for hematotoxicity of chemotherapy in aggressive non-Hodgkin’s lymphoma

A long-term follow-up study of prospective 80%-dose CHOP followed by involved-field radiotherapy in elderly lymphoma patients

The role of positron emission tomography (PET) in the management of lymphoma patients

Chemotherapy for malignant lymphoma in Western countries and Japan

Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma

Recent progress in the treatment of malignant lymphoma

Aggressive primary hepatic lymphoma in chinese patients. Presentation, pathologic features, and outcome

Sternal resection for primary or secondary tumors

A randomized EPOCH vs. CHOP front-line therapy for aggressive non-Hodgkin's lymphoma patients: Long-term results

Aktive Filter

Suchergebnisse filtern